Regenxbio RGNX Cash Flow Statement (2014-2026)

NASDAQ RGNX
$8.94 -0.26 (-2.83%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Regenxbio Quarterly Cash Flow Statement

Periods 47 quarters
Latest Jun 2026

Regenxbio cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 47 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-57.64M-58.41M277.82M-76.72M-68.18M-75.48M-1.13M-66.68M-72.06M-61.87M-63.04M-63.37M-53.02M-59.62M-51.27M6.06M-70.89M-61.96M-67.17M22.69M
Share-based CompensationStock Comp.
13.91M13.91M9.16M15.63M15.63M15.63M9.41M17.36M17.36M17.36M8.34M19.12M19.12M19.12M9.54M65.80M11.81M57.20M8.38M53.20M
Asset Writedowns and ImpairmentWritedown
2.10M
Cash from OperationsCash from Ops.
-36.07M-42.50M341.50M-55.91M-61.75M-50.46M-39.37M-80.92M-47.32M-49.41M-40.76M-55.45M-45.50M-40.55M-31.62M33.63M-49.34M-55.96M-52.29M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
-1.58M-1.51M-1.47M-1.46M-1.22M-1.13M-0.90M-0.68M-0.38M0.13M0.24M0.47M1.24M1.32M1.12M1.07M1.36M1.82M1.23M
Depreciation & Amortization (CF)Dep. & Amort.
2.20M2.83M2.64M2.59M2.64M3.55M4.13M4.18M4.43M4.37M4.33M4.18M4.05M3.96M4.02M3.96M3.90M3.89M3.87M
Change in Working Capital
Change in ReceivablesChange Receivables
3.10M6.40M-22.00M-5.69M10.72M-5.01M-4.84M-9.49M2.39M6.54M-3.37M-9.18M6.89M0.71M-8.13M-1.57M2.36M6.31M0.56M
Change in Account PayablesChange Payables
-1.12M7.35M-8.81M16.75M-7.23M7.36M1.91M-3.10M-11.01M10.10M1.22M8.46M-14.91M3.12M3.04M-3.65M2.53M0.69M-1.86M
Change in Accured ExpensesChange Accured Exp.
4.66M6.35M29.43M-26.47M0.88M-2.65M2.62M-15.44M18.94M-6.14M0.12M-17.08M9.53M4.88M-9.45M-14.49M11.52M-0.02M-0.01M
Other Working Capital ChangesOther WC Changes
2.23M0.20M4.01M-3.04M1.61M-1.32M2.50M13.65M-0.81M0.73M-3.03M6.83M-3.86M-0.17M-9.31M2.24M3.35M-0.01M-6.24M
Investing Activities
Capital ExpendituresCapex
19.84M18.70M14.61M10.97M9.24M5.05M5.47M4.82M2.58M1.44M1.13M-0.59M-1.27M3.22M1.08M1.02M-3.15M4.03M0.51M
Change in Acquisitions & DivestmentsChange Acquisitions
36.01M49.92M33.70M49.86M37.03M72.12M44.13M67.91M107.59M56.25M53.74M68.93M82.73M86.78M51.79M64.92M71.10M82.24M100.86M
Cash from Investing ActivitiesCash from Investing
7.80M16.10M-216.36M-90.59M-1.08M53.04M26.70M63.09M55.22M38.66M33.97M13.18M-0.27M50.26M40.27M44.74M-140.44M42.29M37.54M
Financing Activities
Other financing activitiesOther financing
0.28M1.73M1.00M0.62M1.22M0.92M0.04M0.58M0.64M3.65M131.60M-0.25M-0.28M0.31M0.74M
Cash from Financing ActivitiesCash from Financing
-6.14M-2.28M-7.62M-6.83M-7.67M-5.42M-8.92M-9.04M-9.16M-4.80M-11.96M120.72M-9.45M-10.86M-7.74M-5.79M139.23M-7.08M-9.58M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
1.44M1.22M1.49M1.49M1.72M1.45M2.31M2.03M2.44M
Net Equity Issued and RepurchasedNet Equity Issued
131.10M18.90M
Additional items
Change in Cash
-34.41M-28.68M117.52M-153.34M-70.50M-2.83M-21.59M-26.86M-1.27M-15.55M-18.75M78.45M-55.21M-1.15M0.91M72.58M-50.55M-20.76M-24.34M
Free Cash FlowFCF
-55.91M-61.20M326.88M-66.88M-70.99M-55.51M-44.84M-85.74M-49.90M-50.85M-41.89M-54.87M-44.23M-43.77M-32.70M32.60M-46.20M-59.99M-52.80M
Net Cash FlowNCF
-34.41M-28.68M117.52M-153.34M-70.50M-2.83M-21.59M-26.86M-1.27M-15.55M-18.75M78.45M-55.21M-1.15M0.91M72.58M-50.55M-20.76M-24.34M